ESB, or electrical stimulation of the brain, is a medical technique that uses electrical currents to activate or suppress nerve cell activity in specific brain regions. It encompasses several different technologies, from surgically implanted electrodes to devices that work through the skull without any incision. ESB is used to treat neurological and psychiatric conditions like Parkinson’s disease, epilepsy, and chronic pain, particularly when medications alone aren’t enough.
How Electrical Brain Stimulation Works
The basic principle behind ESB is straightforward: electrical currents can trigger or block the signals that nerve cells use to communicate. When a small electrode delivers current near a nerve cell, it can cause that cell to fire (sending a signal) or go quiet (stopping a signal), depending on the current’s strength, direction, and placement. In most cases, the electrical current acts on the long, wire-like part of the nerve cell (the axon) rather than the cell body itself, and whether a positive or negative current works better depends on the exact position and orientation of the target cells relative to the electrode.
This ability to either activate or suppress brain circuits is what makes ESB versatile. A surgeon can use it to calm an overactive region causing tremors, or to interrupt abnormal electrical patterns that trigger seizures.
Types of Brain Stimulation
Brain stimulation techniques fall into two broad categories: invasive and noninvasive.
Deep Brain Stimulation (DBS)
DBS is the most established invasive form. It requires surgically implanting thin electrodes into specific deep brain structures, connected by wires under the skin to a battery-powered pulse generator typically placed near the collarbone. Because the electrodes sit directly inside the brain, DBS can target precise clusters of cells with high accuracy. The tradeoff is surgical risk, including a small chance of bleeding or infection at the implant site.
Noninvasive Techniques
Transcranial magnetic stimulation (TMS) uses a magnetic coil held against the scalp to generate electrical currents in the brain without surgery. Transcranial direct current stimulation (tDCS) sends a weak electrical current between electrodes placed on the scalp. Both are painless and done in outpatient settings. Their limitation is that magnetic and electric signals get scattered and absorbed as they pass through skull and brain tissue, making it harder to reach deep brain structures or target a very specific area.
Conditions Treated With ESB
The best-known use of ESB is for Parkinson’s disease. One study found that motor scores improved 53% after two years with DBS, compared to just 4% improvement in patients relying on medication alone. DBS doesn’t cure Parkinson’s, but it can dramatically reduce tremor, stiffness, and slowness of movement, often allowing patients to lower their medication doses.
Epilepsy is another major application. The FDA approved two distinct brain stimulation systems for adults with focal epilepsy who haven’t achieved seizure control after trying three or more medications. The first, approved in 2013, is a responsive system that continuously monitors brain activity and delivers stimulation only when it detects the electrical signature of a seizure beginning. The second, approved in 2018, delivers continuous stimulation to a brain structure involved in seizure spread. A long-term follow-up of the continuous stimulation approach showed lasting reductions in seizure frequency over seven years, along with meaningful quality-of-life improvements.
TMS has FDA clearance for treatment-resistant depression and is also used for obsessive-compulsive disorder. tDCS is actively studied for depression, stroke recovery, and chronic pain, though it has fewer formal approvals.
What the Procedure Looks Like
For DBS, the surgery itself typically takes about four hours, with total time under anesthesia averaging around five hours. The surgeon uses brain imaging to map precise coordinates for electrode placement before making a small opening in the skull. Patients generally wake up two to four hours after anesthesia ends, though in some cases it can take longer.
Hospital stays average around 17 days, and the pulse generator is usually programmed and fine-tuned during follow-up visits over the weeks and months after surgery. Finding the right stimulation settings is an iterative process, with adjustments made based on how symptoms respond.
Noninvasive options are far simpler. A typical TMS session lasts 20 to 40 minutes, requires no anesthesia, and you can drive yourself home afterward. tDCS sessions are similarly brief and low-key.
Side Effects and Risks
For noninvasive techniques like TMS and tDCS, side effects are generally mild: itching or tingling at the electrode or coil site, occasional mild headache, warmth, fatigue, or brief dizziness. Serious complications from standard noninvasive stimulation are rare.
DBS carries the risks associated with any brain surgery, primarily bleeding and infection at the implant site. After surgery, some patients experience speech difficulties, balance problems, or tingling sensations, though many of these can be reduced by adjusting stimulation settings. Hardware-related issues also come up over time. Fixed-life batteries in the implanted pulse generator typically need replacement every three to five years, and battery depletion is the most common reason DBS patients need additional surgery. Rechargeable models last longer but require patients to recharge the device every few days using a handheld charger held against the chest, which can be physically challenging for elderly patients or those with significant motor difficulties.
Adaptive Stimulation: The Next Generation
Current DBS devices are “open-loop,” meaning they deliver constant stimulation at fixed settings regardless of what the brain is doing at any given moment. This continuous approach can lose effectiveness over time as the nervous system adapts, and it doesn’t account for natural fluctuations in symptoms throughout the day.
Closed-loop or adaptive DBS aims to solve this by reading brain signals in real time and delivering stimulation only when it’s needed. Clinical trials are testing this approach for chronic pain, using implanted devices that can both record brain activity and stimulate. The idea is to identify electrical patterns that correspond to worsening symptoms and use those patterns as triggers for targeted stimulation. If successful, this could reduce tolerance, extend battery life, and personalize treatment in a way that static settings cannot.